Trials / Conditions / Stage IV Squamous Cell Lung Carcinoma
Stage IV Squamous Cell Lung Carcinoma
3 registered clinical trials studyying Stage IV Squamous Cell Lung Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung Cancer NCT02536495 | Erin Bertino | Phase 1 / Phase 2 |
| Completed | Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Bioma NCT02785913 | SWOG Cancer Research Network | Phase 2 |
| Terminated | S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage NCT00946712 | SWOG Cancer Research Network | Phase 3 |